(Q46142720)

English

Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma

scientific article published in March 2001

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11305717

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/11305717

title

Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11305717

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/11305717

2

Seeger RC

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11305717

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/11305717

author name string

Reynolds CP

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11305717

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/11305717

publication date

1 March 2001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11305717

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/11305717

published in

Journal of Pediatric Hematology/Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11305717

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/11305717

volume

23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11305717

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/11305717

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11305717

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/11305717

page(s)

150-152

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11305717

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/11305717

Identifiers

DOI

10.1097/00043426-200103000-00005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11305717

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/11305717

PubMed publication ID

11305717

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11305717

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/11305717

(Q46142720)

Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)